|
Begrüssung/Agenda
Georg Göstl, Baxter AG
GMP für Wirkstoffe
Dr. Markus Thiel, Roche Austria GmbH
Guideline on setting health based exposure
limits for use in risk identification in the
manufacture of different medicinal products
in shared facilities
Dr. Wolfgang Zauner
Zusammenfassung EQPA Forum 2014
Georg Göstl, Baxter AG
Gabriela Schallmeiner, Inspection-Ready Consulting
|
